Gastric infection by Helicobacter pylori

Curr Gastroenterol Rep. 2011 Dec;13(6):540-6. doi: 10.1007/s11894-011-0226-4.

Abstract

Helicobacter pylori infects half of the world's population and plays a causal role in ulcer disease and gastric cancer. This pathogenic neutralophile uniquely colonizes the acidic gastric milieu through the process of acid acclimation. Acid acclimation is the ability of the organism to maintain periplasmic pH near neutrality in an acidic environment to prevent a fall in cytoplasmic pH in order to maintain viability and growth in acid. Recently, due to an increase in antibiotic resistance, the rate of H. pylori eradication has fallen below 80% generating renewed interest in novel eradication regimens and targets. In this article, we review the gastric biology of H. pylori and acid acclimation, various detection procedures, antibiotic resistance and the role that gastric acidity plays in the susceptibility of the organism to antibiotics currently in use and propose several novel drug targets that would promote eradication in the absence of antibiotics.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Proteins / antagonists & inhibitors
  • Drug Discovery
  • Helicobacter Infections / diagnosis
  • Helicobacter Infections / drug therapy*
  • Helicobacter Infections / microbiology*
  • Helicobacter pylori / physiology*
  • Histamine H2 Antagonists / therapeutic use
  • Humans
  • Membrane Transport Proteins
  • Proton Pump Inhibitors / therapeutic use
  • Stomach Diseases / diagnosis
  • Stomach Diseases / drug therapy*
  • Stomach Diseases / microbiology*
  • Urease / antagonists & inhibitors

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Histamine H2 Antagonists
  • Membrane Transport Proteins
  • Proton Pump Inhibitors
  • UreI protein, Helicobacter pylori
  • Urease